
Alida Biosciences: Pioneering next-gen RNA analysis tools for advanced medical treatments & diagnostics.
Founded with a mission to revolutionize RNA analysis, Alida Biosciences is dedicated to developing cutting-edge tools for advanced medical treatments and diagnostic assays. The company focuses on creating next-generation epigenetic analysis technology, which aims to empower research, therapeutics, and diagnostics by understanding complex gene regulation relationships. Their products include early access reagent kits for multiplexed epitranscriptome analysis, catering to the needs of the medical and scientific research communities.
Alida Biosciences has attracted notable investors and affiliated experts in the field of biotechnology and genomics. The company's pioneering efforts have led to significant advancements in multiomics tools for epigenomic discovery, positioning them as a leader in the RNA analysis space. Their innovative solutions have had a substantial impact on the ability to conduct detailed genetic and epigenetic research, paving the way for new medical breakthroughs and improved diagnostic capabilities.
Alida Biosciences' most recent funding round was for $4M (USD) in May 2022.
As of May 11, 2022, Alida Biosciences has disclosed funding of $5.1M (USD).

RealSeq Biosciences

Epigentek Group
epigentek.com

Eclipse Bioinnovations
eclipsebio.com

Epicrispr Biotechnologies
epicrispr.com

Wayfinder Biosciences
wayfinderbio.com

Zymo Research
zymoresearch.com

Quadrant Biosciences

Element Biosciences

Airna
airna.com

ClearNote Health

Inceptive
inceptive.life

EpiCypher
epicypher.com

Ochre Bio
ochre-bio.com

ReviR Therapeutics
revirtx.com

Ribometrix
ribometrix.com

Ontera
ontera.bio

AtlasXomics
atlasxomics.com

Accelevir Diagnostics

Circular Genomics

Laronde
laronde.bio